1. Home
  2. BFAM vs CORT Comparison

BFAM vs CORT Comparison

Compare BFAM & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Horizons Family Solutions Inc.

BFAM

Bright Horizons Family Solutions Inc.

HOLD

Current Price

$82.68

Market Cap

3.6B

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$92.95

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFAM
CORT
Founded
1986
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
9.7B
IPO Year
2012
2001

Fundamental Metrics

Financial Performance
Metric
BFAM
CORT
Price
$82.68
$92.95
Analyst Decision
Buy
Buy
Analyst Count
7
5
Target Price
$114.57
$96.50
AVG Volume (30 Days)
813.0K
1.0M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
40.00
N/A
EPS
0.62
N/A
Revenue
$1,903,182,000.00
$761,407,000.00
Revenue This Year
$8.19
$26.08
Revenue Next Year
$5.83
$26.98
P/E Ratio
$130.08
N/A
Revenue Growth
N/A
12.79
52 Week Low
$57.63
$28.66
52 Week High
$130.76
$97.63

Technical Indicators

Market Signals
Indicator
BFAM
CORT
Relative Strength Index (RSI) 67.88 57.06
Support Level $79.64 $76.41
Resistance Level $85.77 $95.11
Average True Range (ATR) 2.80 4.33
MACD 0.42 -0.65
Stochastic Oscillator 94.56 62.90

Price Performance

Historical Comparison
BFAM
CORT

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; Full-service center-based child care, Backup care, and Educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: